Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Net Cash Flow (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Net Cash Flow for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 14311.36% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 293.15% year-over-year, with the annual reading at $1.4 million for FY2025, 311.87% up from the prior year.
  • Net Cash Flow hit $1.0 million in Q4 2025 for Mangoceuticals, up from $380307.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $3.2 million in Q1 2023 to a low of -$1.7 million in Q3 2023.
  • Historically, Net Cash Flow has averaged $61769.8 across 3 years, with a median of $1571.0 in 2024.
  • Biggest five-year swings in Net Cash Flow: tumbled 122.7% in 2024 and later surged 14311.36% in 2025.
  • Year by year, Net Cash Flow stood at -$497741.0 in 2023, then soared by 98.58% to -$7077.0 in 2024, then soared by 14311.36% to $1.0 million in 2025.
  • Business Quant data shows Net Cash Flow for MGRX at $1.0 million in Q4 2025, $380307.0 in Q3 2025, and $24336.0 in Q2 2025.